December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Quantification of Intraocular Endostatin; A Newly Identified Angiogenesis Inhibitor
Author Affiliations & Notes
  • C-C Wu
    Ophthalmology Veterans General Hospital Taipei Taiwan Republic of China
  • S-J Chen
    Taipei Taiwan Republic of China
  • J-H Liu
    Taipei Taiwan Republic of China
  • S-M Lee
    Taipei Taiwan Republic of China
  • W-M Hsu
    Taipei Taiwan Republic of China
  • Footnotes
    Commercial Relationships   C. Wu, None; S. Chen , None; J. Liu , None; S. Lee , None; W. Hsu, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1750. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C-C Wu, S-J Chen, J-H Liu, S-M Lee, W-M Hsu; Quantification of Intraocular Endostatin; A Newly Identified Angiogenesis Inhibitor . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1750.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:Endostatin is a newly identified angiogenic inhibitor. The aims of the study are to quantify normal human intraocular endostatin and to compare aqueous levels between normal and herpetic keratitis with corneal neovascularization. Methods:Aqueous(N=17)and serum(N=10)samples were collected from patients during cataract operations. Twelve control cases were senile cataract and five cases had corneal neovascularization due to old herpetic keratitis. Undiluted vitreous samples(N=13) were collected during vitrectomy from macular pucker(N=4), macular hole(N=4), Coats' disease(N=1), and cataract operation complicated with vitreous loss(N=4). Samples were stored then quantified by ELISA technique. Results:The average level of endostatin was 24+ 10.5 ng/ml in serum. The average level of endostatin was 8.9+2.5 ng/ml in normal aqueous and 7.4+1.0 ng/ml in aqueous with corneal neovascularization. They were not significantly different(Mann-Whitney U test, p=0.1). As the level in vitreous from Coats' disease was too high(159.9 ng/ml),so this data was excluded from the study for the normal average. The average level in vitreous(N=12) was 15.0+8.5 ng/ml, and was higher than aqueous level(Mann-Whitney U test, p<0.01). Both aqueous and vitreous level were lower than serum(Mann-Whitney U test, p<0.01 and p=0.01,respectively). Conclusion:Eye contains at least two kinds of endogenous angiogenic inhibitors, pigment epithelium-derived factor(PEDF) and endostatin. Only endostatin can not explain the avascularity of vitreous. Aqueous endostatin was not significantly related to corneal neovascularization in our study. Angiogenesis should be modulated by multiple angiogenic factors and multiple inhibitors. Besides anti-angionenic effect, endostatin can be an indicator of pathological changes of vessels such as telangiectasis in Coats' disease. Endostatin is multi-functional just like PEDF.

Keywords: 483 neovascularization • 324 aqueous • 629 vitreous 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.